After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more

StreetInsider2021-09-17

After-Hours Stock Movers: AbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

287

Report

Comment（24）

STKG
·2021-09-17
Good to know
Reply
3
Report
CWL711
·2021-09-17
Like thanks
Reply
3
Report
Fold Replies
- Vincewjs:
  done
  2021-09-17
  Reply
  Report
winterflower
·2021-09-17
Like pls thank you
Reply
6
Report
Fold Replies
- JohnL:
  Done
  2021-09-17
  Reply
  Report
Zhem
·2021-09-17
Ho
Reply
6
Report
Fold Replies
- tan0524u:
  Ok
  2021-09-17
  Reply
  Report
Hayleypang
·2021-09-17
Ho
Reply
6
Report
jochen
·2021-09-17
?
Reply
3
Report
pointe
·2021-09-17
?
Reply
6
Report
小虎一飞冲天
·2021-09-17
Like pls. thanks.
Reply
6
Report
Fold Replies
- Akadken:
  ✌?
  2021-09-17
  Reply
  Report
- eveevelyn:
  ok
  2021-09-17
  Reply
  Report
Dcagency
·2021-09-17
Good info
Reply
8
Report
Fold Replies
- koolgal:
  ??
  2021-09-17
  Reply
  Report
KeatWei
·2021-09-17
Like
Reply
8
Report
Fold Replies
- Aun9:
  Hi
  2021-09-17
  Reply
  Report
- Dcagency:
  Done
  2021-09-17
  Reply
  Report
- Akadken:
  ✌?
  2021-09-17
  Reply
  Report
View more 1 comments
Bentofighter
·2021-09-17
Pls like
Reply
8
Report
Fold Replies
- KeatWei:
  ??
  2021-09-17
  Reply
  Report
- Akadken:
  ✌?
  2021-09-17
  Reply
  Report
JoelLee
·2021-09-17
Reply and comment pls thx!
Reply
9
Report
Fold Replies
- spcenbeyond:
  ok
  2021-09-17
  Reply
  Report
- JoelLee:
  Ahahjajauaauuau
  2021-09-17
  Reply
  Report
- Sataneson:
  Ok
  2021-09-17
  Reply
  Report
View more 2 comments
Akyl
·2021-09-17
Great
Reply
6
Report
Baby Step 4
·2021-09-17
Yup
Reply
6
Report
Baby Step 4
·2021-09-17
Tell me your opinion about this news...
Reply
3
Report
HeoMoi
·2021-09-17
Great
Reply
10
Report
saral
·2021-09-17
Sure
Reply
7
Report
Spaclover
·2021-09-17
T
Reply
6
Report
Fold Replies
- Spaclover:
  T
  2021-09-17
  Reply
  Report
Elsontok
·2021-09-17
please like
Reply
14
Report
Fold Replies
- Akadken:
  ✌?
  2021-09-17
  Reply
  Report
- Wafu:
  Done
  2021-09-17
  Reply
  Report
- saral:
  Sure.
  2021-09-17
  Reply
  Report
View more 1 comments
EeHoe
·2021-09-17
gl
Reply
5
Report
Fold Replies
- EeHoeReplying toEeHoe:
  [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]
  2021-09-17
  Reply
  Report
- EeHoeReplying toEeHoe:
  [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]
  2021-09-17
  Reply
  Report
- EeHoeReplying toEeHoe:
  [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]
  2021-09-17
  Reply
  Report
View more 2 comments

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2168542123?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-17 07:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2168542123","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FANG","symbol_name":"Diamondback Energy","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","article_id":"2168542123","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","pubTimestamp":1631835720,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁","GRTS":"Gritstone Oncology Inc."},"translate_title":"盘后股票搬运工：AbCellera生物制品公司、美国钢铁公司、响尾蛇能源公司等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABCL":0.9,"FANG":0.9,"GRTS":0.9,"X":0.9},"content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":884338058,"gmtCreate":1631854553974,"gmtModify":1676530653436,"author":{"id":"3586131488444401","authorId":"3586131488444401","name":"STKG","avatar":"https://static.tigerbbs.com/730c2482b43ac1909a601868b378a6e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586131488444401","authorIdStr":"3586131488444401"},"htmlText":"Good to know","listText":"Good to know","text":"Good to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884338058","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884975147,"gmtCreate":1631851862189,"gmtModify":1676530652773,"author":{"id":"3579262958727025","authorId":"3579262958727025","name":"CWL711","avatar":"https://static.tigerbbs.com/982058e5cb33e9069dbb2ca28d3fc46e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579262958727025","authorIdStr":"3579262958727025"},"htmlText":"Like thanks","listText":"Like thanks","text":"Like thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884975147","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5902384,"gmtCreate":1631874179518,"gmtModify":1663234021940,"authorId":3580530961144265,"author":{"id":3580530961144265,"idStr":"3580530961144265","authorId":3580530961144265,"name":"Vincewjs","avatar":"https://static.tigerbbs.com/b82f615cebf44420a077b013694f231d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884975147,"type":1,"supId":0,"prevId":0,"content":"<u>done</u>","text":"<u>done</u>","html":"<u>done</u>"}],"langContent":"EN"},{"id":884990724,"gmtCreate":1631844080168,"gmtModify":1676530650537,"author":{"id":"3575500119873947","authorId":"3575500119873947","name":"winterflower","avatar":"https://static.tigerbbs.com/eeb88638c0d0fc78384e4f7a7514daaa","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575500119873947","authorIdStr":"3575500119873947"},"htmlText":"Like pls thank you","listText":"Like pls thank you","text":"Like pls thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884990724","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5898842,"gmtCreate":1631848387859,"gmtModify":1663234004925,"authorId":3570369418287680,"author":{"id":3570369418287680,"idStr":"3570369418287680","authorId":3570369418287680,"name":"JohnL","avatar":"https://community-static.tradeup.com/news/20db2fa4f65cb04a8d837d400a1b5d7b","vip":1,"currentWearingBadge":{"badgeId":"cbe1c45c584340f3bd9ae6c77e0e9981-1","templateUuid":"cbe1c45c584340f3bd9ae6c77e0e9981","name":"Academy Experiencer","description":"5 lessons learned","bigImgUrl":"https://community-static.tradeup.com/news/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://community-static.tradeup.com/news/c2660a1935bd2105e97c9915619936c3","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.06","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2006},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884990724,"type":1,"supId":0,"prevId":0,"content":"<u>Done</u>","text":"<u>Done</u>","html":"<u>Done</u>"}],"langContent":"EN"},{"id":884076553,"gmtCreate":1631843037872,"gmtModify":1676530650058,"author":{"id":"3575931986549530","authorId":"3575931986549530","name":"Zhem","avatar":"https://static.tigerbbs.com/a416161c2f96e83b8298ad7bdd893247","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575931986549530","authorIdStr":"3575931986549530"},"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884076553","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5897940,"gmtCreate":1631843669536,"gmtModify":1663234001737,"authorId":3567505470517950,"author":{"id":3567505470517950,"idStr":"3567505470517950","authorId":3567505470517950,"name":"tan0524u","avatar":"https://static.tigerbbs.com/36ccaf6467346df7588feaddbaa96926","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884076553,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":884076142,"gmtCreate":1631843014886,"gmtModify":1676530650083,"author":{"id":"3581078517760821","authorId":"3581078517760821","name":"Hayleypang","avatar":"https://static.tigerbbs.com/06187d3b93a8476aece6ade7f24f4c5a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581078517760821","authorIdStr":"3581078517760821"},"htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884076142","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884044468,"gmtCreate":1631842712054,"gmtModify":1676530649930,"author":{"id":"4094824274303910","authorId":"4094824274303910","name":"jochen","avatar":"https://static.tigerbbs.com/5c1f2c08c8fd5f34bc708bc9415c25c1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4094824274303910","authorIdStr":"4094824274303910"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884044468","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884049582,"gmtCreate":1631842298546,"gmtModify":1676530649728,"author":{"id":"4093612570926840","authorId":"4093612570926840","name":"pointe","avatar":"https://static.tigerbbs.com/2228225cd04d557ec97467028247a938","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4093612570926840","authorIdStr":"4093612570926840"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884049582","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884060503,"gmtCreate":1631840258502,"gmtModify":1676530648979,"author":{"id":"3582098623642517","authorId":"3582098623642517","name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582098623642517","authorIdStr":"3582098623642517"},"htmlText":"Like pls. thanks.","listText":"Like pls. thanks.","text":"Like pls. thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884060503","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5897040,"gmtCreate":1631840745137,"gmtModify":1663233997746,"authorId":4089155539472820,"author":{"id":4089155539472820,"idStr":"4089155539472820","authorId":4089155539472820,"name":"Akadken","avatar":"https://static.tigerbbs.com/f9d2d75bd697950ef6eeae6a89bfb9f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884060503,"type":1,"supId":0,"prevId":0,"content":"✌?","text":"✌?","html":"✌?"},{"id":5897814,"gmtCreate":1631843083924,"gmtModify":1631889604445,"authorId":3584446268894368,"author":{"id":3584446268894368,"idStr":"3584446268894368","authorId":3584446268894368,"name":"eveevelyn","avatar":"https://static.tigerbbs.com/7b409079dc1ccbaa3b0917074d3bef1b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884060503,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":884084763,"gmtCreate":1631840170952,"gmtModify":1676530648947,"author":{"id":"3557142354281361","authorId":"3557142354281361","name":"Dcagency","avatar":"https://static.tigerbbs.com/811d507c3458decd0eacd9028472dcf4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3557142354281361","authorIdStr":"3557142354281361"},"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/884084763","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5899566,"gmtCreate":1631852510030,"gmtModify":1634796841739,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"currentWearingBadge":{"badgeId":"c4ee29b388ff41cc8462b3b7ea00d1e2-1","templateUuid":"c4ee29b388ff41cc8462b3b7ea00d1e2","name":"Monthly Top Contributor","description":"Top 3 Contributors with the most and best Editor's Picks every month","bigImgUrl":"https://static.tigerbbs.com/b0cad6192443c33dca826a001250fbd4","smallImgUrl":"https://static.tigerbbs.com/5ccd98c646815ce7610b0df338e060cc","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2003},"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.21","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":884084763,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"}],"langContent":"EN"},{"id":884083075,"gmtCreate":1631839731197,"gmtModify":1676530648638,"author":{"id":"3586408007231136","authorId":"3586408007231136","name":"KeatWei","avatar":"https://static.tigerbbs.com/888c5c9e15d9720e77d1799e3ef80e42","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586408007231136","authorIdStr":"3586408007231136"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/884083075","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5897633,"gmtCreate":1631842550577,"gmtModify":1663234002329,"authorId":3575694115795487,"author":{"id":3575694115795487,"idStr":"3575694115795487","authorId":3575694115795487,"name":"Aun9","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884083075,"type":1,"supId":0,"prevId":0,"content":"Hi","text":"Hi","html":"Hi"},{"id":5896872,"gmtCreate":1631840151689,"gmtModify":1663234000742,"authorId":3557142354281361,"author":{"id":3557142354281361,"idStr":"3557142354281361","authorId":3557142354281361,"name":"Dcagency","avatar":"https://static.tigerbbs.com/811d507c3458decd0eacd9028472dcf4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884083075,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5897046,"gmtCreate":1631840761119,"gmtModify":1663234000741,"authorId":4089155539472820,"author":{"id":4089155539472820,"idStr":"4089155539472820","authorId":4089155539472820,"name":"Akadken","avatar":"https://static.tigerbbs.com/f9d2d75bd697950ef6eeae6a89bfb9f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884083075,"type":1,"supId":0,"prevId":0,"content":"✌?","text":"✌?","html":"✌?"},{"id":5896850,"gmtCreate":1631840072552,"gmtModify":1663233997635,"authorId":3582350348015234,"author":{"id":3582350348015234,"idStr":"3582350348015234","authorId":3582350348015234,"name":"Ag1718","avatar":"https://community-static.tradeup.com/news/7b99db6dd9dd4eaa84bd8baf04aad0b9","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884083075,"type":1,"supId":0,"prevId":0,"content":"Like . reply back thanks.?","text":"Like . reply back thanks.?","html":"Like . reply back thanks.?"}],"langContent":"EN"},{"id":884014594,"gmtCreate":1631839517118,"gmtModify":1676530648561,"author":{"id":"3583478720415511","authorId":"3583478720415511","name":"Bentofighter","avatar":"https://static.tigerbbs.com/3d3b444e1397cd8d1ec1b18c5c8c5db5","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"3583478720415511","authorIdStr":"3583478720415511"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884014594","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5896786,"gmtCreate":1631839741424,"gmtModify":1663233997749,"authorId":3586408007231136,"author":{"id":3586408007231136,"idStr":"3586408007231136","authorId":3586408007231136,"name":"KeatWei","avatar":"https://static.tigerbbs.com/888c5c9e15d9720e77d1799e3ef80e42","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884014594,"type":1,"supId":0,"prevId":0,"content":"??","text":"??","html":"??"},{"id":5897053,"gmtCreate":1631840774449,"gmtModify":1663233997526,"authorId":4089155539472820,"author":{"id":4089155539472820,"idStr":"4089155539472820","authorId":4089155539472820,"name":"Akadken","avatar":"https://static.tigerbbs.com/f9d2d75bd697950ef6eeae6a89bfb9f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884014594,"type":1,"supId":0,"prevId":0,"content":"✌?","text":"✌?","html":"✌?"}],"langContent":"EN"},{"id":884097797,"gmtCreate":1631838416419,"gmtModify":1676530648158,"author":{"id":"3579882572140125","authorId":"3579882572140125","name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":1,"crmLevelSwitch":1,"idStr":"3579882572140125","authorIdStr":"3579882572140125"},"htmlText":"Reply and comment pls thx!","listText":"Reply and comment pls thx!","text":"Reply and comment pls thx!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/884097797","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5899347,"gmtCreate":1631850964544,"gmtModify":1663234006043,"authorId":3571890541915645,"author":{"id":3571890541915645,"idStr":"3571890541915645","authorId":3571890541915645,"name":"spcenbeyond","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884097797,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5896466,"gmtCreate":1631838428599,"gmtModify":1663233998435,"authorId":3579882572140125,"author":{"id":3579882572140125,"idStr":"3579882572140125","authorId":3579882572140125,"name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.08","exceedPercentage":"80.58%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":1,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884097797,"type":1,"supId":0,"prevId":0,"content":"Ahahjajauaauuau","text":"Ahahjajauaauuau","html":"Ahahjajauaauuau"},{"id":5896656,"gmtCreate":1631839353748,"gmtModify":1663233998344,"authorId":3581730902365980,"author":{"id":3581730902365980,"idStr":"3581730902365980","authorId":3581730902365980,"name":"Sataneson","avatar":"https://static.tigerbbs.com/eca31f563085f3549f3adfa11debfd90","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884097797,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"},{"id":5897057,"gmtCreate":1631840789870,"gmtModify":1663233997549,"authorId":4089155539472820,"author":{"id":4089155539472820,"idStr":"4089155539472820","authorId":4089155539472820,"name":"Akadken","avatar":"https://static.tigerbbs.com/f9d2d75bd697950ef6eeae6a89bfb9f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884097797,"type":1,"supId":0,"prevId":0,"content":"✌?","text":"✌?","html":"✌?"},{"id":5896712,"gmtCreate":1631839510579,"gmtModify":1663233995534,"authorId":3583478720415511,"author":{"id":3583478720415511,"idStr":"3583478720415511","authorId":3583478720415511,"name":"Bentofighter","avatar":"https://static.tigerbbs.com/3d3b444e1397cd8d1ec1b18c5c8c5db5","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.03%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":884097797,"type":1,"supId":5896656,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":884094761,"gmtCreate":1631838372153,"gmtModify":1676530648151,"author":{"id":"4087134384226650","authorId":"4087134384226650","name":"Akyl","avatar":"https://community-static.tradeup.com/news/729fa63ccba161ab17b5ceba58217197","vip":1,"crmLevel":3,"crmLevelSwitch":1,"idStr":"4087134384226650","authorIdStr":"4087134384226650"},"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884094761","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884007095,"gmtCreate":1631837956417,"gmtModify":1676530647839,"author":{"id":"3585617155516823","authorId":"3585617155516823","name":"Baby Step 4","avatar":"https://static.tigerbbs.com/8ee1c9c06b2929c88e9f5bb3a24cf2d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585617155516823","authorIdStr":"3585617155516823"},"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884007095","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884004942,"gmtCreate":1631837900886,"gmtModify":1676530647817,"author":{"id":"3585617155516823","authorId":"3585617155516823","name":"Baby Step 4","avatar":"https://static.tigerbbs.com/8ee1c9c06b2929c88e9f5bb3a24cf2d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585617155516823","authorIdStr":"3585617155516823"},"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884004942","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":884009133,"gmtCreate":1631837582722,"gmtModify":1676530647670,"author":{"id":"3586717747076728","authorId":"3586717747076728","name":"HeoMoi","avatar":"https://static.tigerbbs.com/cd9a6f58d920c83ea98052a3d88760b6","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586717747076728","authorIdStr":"3586717747076728"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/884009133","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":885777376,"gmtCreate":1631837433295,"gmtModify":1676530647622,"author":{"id":"3568944508199908","authorId":"3568944508199908","name":"saral","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3568944508199908","authorIdStr":"3568944508199908"},"htmlText":"Sure","listText":"Sure","text":"Sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/885777376","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":885774374,"gmtCreate":1631837398398,"gmtModify":1676530647587,"author":{"id":"3565238397133271","authorId":"3565238397133271","name":"Spaclover","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3565238397133271","authorIdStr":"3565238397133271"},"htmlText":"T","listText":"T","text":"T","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/885774374","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5896118,"gmtCreate":1631837404425,"gmtModify":1663233993642,"authorId":3565238397133271,"author":{"id":3565238397133271,"idStr":"3565238397133271","authorId":3565238397133271,"name":"Spaclover","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":885774374,"type":1,"supId":0,"prevId":0,"content":"T","text":"T","html":"T"}],"langContent":"EN"},{"id":885773726,"gmtCreate":1631837139665,"gmtModify":1676530647469,"author":{"id":"3577246510298951","authorId":"3577246510298951","name":"Elsontok","avatar":"https://static.tigerbbs.com/5d91c4e73ceffea4b93c2c832535db3b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3577246510298951","authorIdStr":"3577246510298951"},"htmlText":"please like","listText":"please like","text":"please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/885773726","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5897061,"gmtCreate":1631840803714,"gmtModify":1663234000650,"authorId":4089155539472820,"author":{"id":4089155539472820,"idStr":"4089155539472820","authorId":4089155539472820,"name":"Akadken","avatar":"https://static.tigerbbs.com/f9d2d75bd697950ef6eeae6a89bfb9f0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":885773726,"type":1,"supId":0,"prevId":0,"content":"✌?","text":"✌?","html":"✌?"},{"id":5896150,"gmtCreate":1631837530661,"gmtModify":1663233996737,"authorId":3575505100092231,"author":{"id":3575505100092231,"idStr":"3575505100092231","authorId":3575505100092231,"name":"Wafu","avatar":"https://static.tigerbbs.com/0fa81128865bb0701d14c8c5b8570921","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.02","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":885773726,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5896139,"gmtCreate":1631837456134,"gmtModify":1663233994739,"authorId":3568944508199908,"author":{"id":3568944508199908,"idStr":"3568944508199908","authorId":3568944508199908,"name":"saral","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":885773726,"type":1,"supId":0,"prevId":0,"content":"Sure.","text":"Sure.","html":"Sure."},{"id":5896200,"gmtCreate":1631837716411,"gmtModify":1663233994043,"authorId":3581562486795328,"author":{"id":3581562486795328,"idStr":"3581562486795328","authorId":3581562486795328,"name":"Newbie_21","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":885773726,"type":1,"supId":0,"prevId":0,"content":"<u>Done</u>","text":"<u>Done</u>","html":"<u>Done</u>"}],"langContent":"EN"},{"id":885770487,"gmtCreate":1631837060249,"gmtModify":1676530647412,"author":{"id":"3569357432940876","authorId":"3569357432940876","name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569357432940876","authorIdStr":"3569357432940876"},"htmlText":"gl","listText":"gl","text":"gl","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":10,"repostSize":0,"link":"https://ttm.financial/post/885770487","repostId":2168542123,"repostType":4,"repost":{"id":"2168542123","pubTimestamp":1631835720,"share":"https://ttm.financial/m/news/2168542123?lang=&edition=fundamental","pubTime":"2021-09-17 07:42","market":"us","language":"en","title":"After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2168542123","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ABCL\">AbCellera Biologics</a> (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.</p>\n<p><a href=\"https://laohu8.com/S/GRTS\">Gritstone Oncology Inc.</a> (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.</p>\n<p><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a>, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.</p>\n<p><a href=\"https://laohu8.com/S/X\">U.S. Steel</a> (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: AbCellera Biologics, U.S. Steel, Diamondback Energy and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-17 07:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18951138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18951138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRTS":"Gritstone Oncology Inc.","FANG":"Diamondback Energy","ABCL":"AbCellera Biologics","X":"美国钢铁"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18951138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168542123","content_text":"After-Hours Stock Movers:\nAbCellera Biologics (Nasdaq: ABCL) 21% HIGHER; announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The neutralizing antibodies, which were authorized together by the FDA in February 2021 to treat early COVID-19 infection, can now also be used together to treat high-risk individuals 12 years of age and older who have not been fully vaccinated against COVID-19 or are not expected to mount an adequate immune response to complete vaccination, and have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting, including a nursing home or prison.\nGritstone Oncology Inc. (Nasdaq: GRTS) 5.1% LOWER; announced a $55.0 million private investment in public equity (PIPE) financing from the sale of 5,000,000 shares of its common stock at a price per share of $11.00. Gross proceeds from the PIPE financings total $55.0 million, before deducting placement agent fees and offering expenses. The PIPE is being led by Frazier Life Sciences Public Fund, with additional participation from Redmile Group and Gilead Sciences.\nDiamondback Energy, Inc. (NASDAQ: FANG) 4.7% HIGHER; announced that it has accelerated its plans to return 50% of Free Cash Flow to stockholders to the fourth quarter of 2021, and the Board of Directors has approved an up to $2.0 billion share repurchase program to complement this return commitment.\nU.S. Steel (NYSE: X) 1.1% LOWER; today provided third quarter 2021 guidance. Third quarter 2021 adjusted EBITDA is expected to be approximately $2.0 billion. This compares to second quarter 2021 adjusted EBITDA of approximately $1.3 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5896007,"gmtCreate":1631837119131,"gmtModify":1663233997328,"authorId":3569357432940876,"author":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3569357432940876,"repliedAuthor":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":885770487,"type":1,"supId":5895979,"prevId":5896005,"content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]"},{"id":5895985,"gmtCreate":1631837079702,"gmtModify":1663233996949,"authorId":3569357432940876,"author":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3569357432940876,"repliedAuthor":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":885770487,"type":1,"supId":5895979,"prevId":5895981,"content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]"},{"id":5895998,"gmtCreate":1631837095904,"gmtModify":1663233996927,"authorId":3569357432940876,"author":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3569357432940876,"repliedAuthor":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":885770487,"type":1,"supId":5895979,"prevId":5895994,"content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]"},{"id":5895989,"gmtCreate":1631837084863,"gmtModify":1663233996643,"authorId":3569357432940876,"author":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3569357432940876,"repliedAuthor":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":885770487,"type":1,"supId":5895979,"prevId":5895985,"content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]"},{"id":5895999,"gmtCreate":1631837101715,"gmtModify":1663233996642,"authorId":3569357432940876,"author":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3569357432940876,"repliedAuthor":{"id":3569357432940876,"idStr":"3569357432940876","authorId":3569357432940876,"name":"EeHoe","avatar":"https://static.tigerbbs.com/cb0c6bece08ddb8d0b70306a6488c1a2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":885770487,"type":1,"supId":5895979,"prevId":5895998,"content":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","text":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]","html":"[微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑] [微笑]"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":287,"commentSize":24,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}